The global pet therapeutic diet market size is anticipated to reach USD 6.44 billion by 2030 and is projected to grow at a CAGR of 7.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by rising pet ownership, increasing awareness of pet health and wellness, and a growing prevalence of chronic conditions like obesity, diabetes, and gastrointestinal disorders in pets. Veterinary recommendations and science-backed formulations are fueling demand for specialized diets customized to manage these issues. In addition, key trends shaping the market include the surge in premium and prescription-based pet foods, increased focus on palatability and digestibility, and strategic collaborations between pet food companies, veterinarians, and regulatory bodies to enhance pet care standards.
Furthermore, a growing collaboration between key industry players and government authorities drives the market growth. For instance, in February 2025, Hill's Pet Nutrition partnered with the Association for Pet Obesity Prevention (APOP) to tackle the growing issue of pet obesity, which affects nearly two-thirds of pets in the U.S. This collaboration focuses on improving communication between veterinarians and pet owners, supporting evidence-based weight management, and addressing bias in veterinary care. The initiative also includes research, educational tools, and campaigns like "End Pet Obesity" to promote healthier lifestyles for pets. These partnerships focus on promoting pet health through evidence-based nutrition, regulatory support, and public awareness initiatives. By aligning standards for pet food safety, clinical efficacy, and educational outreach, such collaborations accelerate innovation and expand access to specialized therapeutic diets, ultimately improving overall pet wellness and veterinary care outcomes.
Growing innovation in wet food technology and an increase in the launch of pet therapeutic diets are driving market growth. For instance, in March 2024, Harley’s Corner launched India’s first domestically produced wet puppy and therapeutic dog food, utilizing advanced processing and precision nutrition to address specific canine health conditions such as renal failure, food allergies, gastrointestinal issues, joint problems, and obesity. With condition-specific formulations and cutting-edge wet food technology, the brand aims to support veterinary professionals in delivering targeted, clinically effective dietary care. This innovation is expected to accelerate the market growth in India by increasing accessibility to specialized diets, promoting clinical nutrition awareness, and supporting veterinary professionals with locally formulated, targeted dietary solutions.
Request a free sample copy or view report summary: Pet Therapeutic Diet Market Report
The dry food segment accounted for the largest market revenue share in 2024 and is anticipated to grow at the fastest CAGR during the forecast period. This is due to its convenience, longer shelf life, cost-effectiveness, and ease of storage and feeding.
Based on animal type, the dog segment accounted for the largest revenue share of the market in 2024, due to higher ownership and diet needs, while the cat segment is set to grow fastest owing to rising cat adoption and increasing awareness of feline-specific health issues.
Based on indication, the obesity care segment accounted for the largest market revenue share in 2024, due to rising pet obesity cases, while the renal care segment is projected to grow at the fastest CAGR of 7.8% during the forecast period, driven by the increasing prevalence of chronic kidney issues in pets.
Based on distribution channel, the veterinary hospitals and clinics segment accounted for the largest market revenue share in 2024, due to increased pet health awareness and the rising prevalence of chronic diseases requiring professional dietary interventions. The e-commerce segment is expected to grow at the fastest CAGR during the forecast period.
North America dominated the market with the largest revenue share of 40% in 2024. The Asia Pacific region is estimated to grow at the fastest CAGR of 8.0% during the forecast period.
Grand View Research has segmented the global pet therapeutic diet market based on product, indication, animal type, distribution channel, and region:
Pet Therapeutic Diet Product Outlook (Revenue, USD Million, 2018 - 2030)
Wet Food
Dry Food
Others
Pet Therapeutic Diet Indication Outlook (Revenue, USD Million, 2018 - 2030)
Renal Care
Obesity Care
Diabetic Care
Dental Care
Gastrointestinal Care
Recovery Care
Joint Care
Oncology (Restorative) Care
Others (Hydrolyzed Care, Urolith Care, Thyroid Care, etc.)
Pet Therapeutic Diet Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Dogs
Cats
Others
Pet Therapeutic Diet Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
E-commerce
Veterinary hospitals & clinics
Retail Pharmacies
Others
Pet Therapeutic Diet Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
Rest of Europe
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Pet Therapeutic Diet Market
Colgate-Palmolive Company (Hill's Pet Nutrition Inc.)
Nestlé
Mars Petcare (Royal Canin)
General Mills Inc. (Blue Buffalo Company, Ltd.)
Diamond Pet Foods, Inc.
Virbac
Veterinary Nutrition Group
Farmina Pet Foods
JustFoodForDogs
EmerAid, LLC
"The quality of research they have done for us has been excellent..."